<!doctype html><html lang="en"><head><meta name="generator" content="Scully 0.0.0"><meta charset="utf-8"><title>Research | Zoldos Group</title><base href="/"><meta name="viewport" content="width=device-width,initial-scale=1"><link rel="icon" type="image/x-icon" href="favicon.ico"><link rel="manifest" href="manifest.webmanifest"><meta name="theme-color" content="#1976d2"><link rel="stylesheet" href="styles.300e1a536fed1c171fa2.css"><style></style><meta name="description" content="This is our research"><meta name="keywords" content="research"><style>.header[_ngcontent-bbw-c9]{padding:10px;flex-wrap:wrap;height:65px;justify-content:space-between}.header-links[_ngcontent-bbw-c9],.header[_ngcontent-bbw-c9]{display:flex;align-items:center}.header-links[_ngcontent-bbw-c9]{justify-content:flex-end;width:70%}.header-logo[_ngcontent-bbw-c9]{width:30%;text-align:left}.links[_ngcontent-bbw-c9]{margin:0 10px}.logo[_ngcontent-bbw-c9]{font-size:35px}</style><style>.research-post[_ngcontent-bbw-c15]{flex-wrap:wrap;justify-content:center;max-width:1400px;width:100%;margin:0 auto}.specifications[_ngcontent-bbw-c15]{background:linear-gradient(90deg,#74ebd5,#acb6e5);text-align:center}h1[_ngcontent-bbw-c15],h2[_ngcontent-bbw-c15],h3[_ngcontent-bbw-c15]{font-family:helvetica}</style><script>window.ScullyIO="generated"</script></head><body scully-version="0.0.0"><zg-root _nghost-bbw-c20="" ng-version="9.1.1"><router-outlet _ngcontent-bbw-c20=""></router-outlet><zg-layout _nghost-bbw-c9=""><header _ngcontent-bbw-c9=""><div _ngcontent-bbw-c9="" class="header"><div _ngcontent-bbw-c9="" class="header-logo"><a _ngcontent-bbw-c9="" routerlink="/" routerlinkactive="" class="logo" href="/">Logo</a></div><div _ngcontent-bbw-c9="" class="header-links"><a _ngcontent-bbw-c9="" routerlinkactive="active" class="links active" href="/">Home</a><a _ngcontent-bbw-c9="" routerlinkactive="active" class="links active" href="/research/">Research</a><a _ngcontent-bbw-c9="" routerlinkactive="active" class="links" href="/lab-members/">Lab Members</a><a _ngcontent-bbw-c9="" routerlinkactive="active" class="links" href="/publications/">Publications</a><a _ngcontent-bbw-c9="" routerlinkactive="active" class="links" href="/news/">News</a><a _ngcontent-bbw-c9="" routerlinkactive="active" class="links" href="/other-info">Other Information</a><a _ngcontent-bbw-c9="" routerlinkactive="active" class="links" href="/photo-gallery/">Photo Gallery</a><a _ngcontent-bbw-c9="" routerlinkactive="active" class="links" href="/contact/">Contact</a></div></div></header><router-outlet _ngcontent-bbw-c9=""></router-outlet><zg-page _nghost-bbw-c19=""><zg-block-renderer _ngcontent-bbw-c19="" _nghost-bbw-c18=""></zg-block-renderer><zg-test-block _nghost-bbw-c15=""><div _ngcontent-bbw-c15=""><h1 _ngcontent-bbw-c15="" class="m-a-s">RESEARCH</h1><h3 _ngcontent-bbw-c15="" class="m-a-s">Here you can read all of our research</h3></div><section _ngcontent-bbw-c15="" class="research-post"><h2 _ngcontent-bbw-c15="" class="m-a-l col-12 ta-center">A Systems medicine approach to chronic inflammatory disease</h2><img _ngcontent-bbw-c15="" src="/assets/images/landing.png"><p _ngcontent-bbw-c15="">A SYSCID consortium aims to develop a system medicine approach for disease prediction in chronic inflammatory diseases (CID). We will focus on three major CID indications with distinct characteristics, yet a large overlap of their molecular risk map: inflammatory bowel disease. systemic lupus erythematosus and rheumatoid arthritis. There are 15 partners from major cohorts and initiatives in Europe joined in this project (i.e. IHEC, ICGC, Twins UK and Meta-HIT) to investigate human dana sets on three major levels of resolution: whole blood signatures, signatures from purified immune cell types (with focus on CD14 and CD4/CD8) and selected single cell analyses. Principle data layers will comprise SNPs, methylome, transcriptome and gut microbiome. Using this set up we will focus on three fundamental aims: (i) the identification of shared and unique «core disease signatures, which are associated with the disease state and independent of temporal variation, (ii) the generation of «predictive models of disease outcome» – builds on previous work that pathways/biomarkers for disease outcome and distinct from initial disease risk may be shared across disease to guide therapy decisions on an individual patient basis, (iii) «reprogramming disease» – will identify and target temporarily stable epigenetic alterations in macrophages and lymphocytes in epigenome editing approaches as biological validation and potential novel therapeutic tools.</p><p _ngcontent-bbw-c15="" class="m-y-m"><b _ngcontent-bbw-c15="">Zoldoš group</b> is involved in SYSCID project within the Workpackage WP9 (led by HUNIMED) by epigenetic reprogamming to cis-regulatory regions (i.e. pathogenic variants associated to CID, previously identified by partner Humanitas University, Milan, Italy) using dCas9 fusions (with activator and repressor domains, and/or epigenetic reader/eraser domains). The main goal is to model the impact of the most relevant pathogenic nucleotide variants on the gene expression programs of myeloid cells and CD8 cells. We will infer the possible functional impact of corrective interventions selectively targeting the activity of the regulatory elements harbouring such variants. Using multiple targeting and orthogonal regulation (simultaneous activation and repression of genes in the same cell) will aim to enable precise pathway shaping.</p><div _ngcontent-bbw-c15="" class="specifications"><p _ngcontent-bbw-c15=""><b _ngcontent-bbw-c15="">Type of funding scheme:</b> RIA; Coordination and support action; Support actions</p><p _ngcontent-bbw-c15="" class="m-y-s"><b _ngcontent-bbw-c15="">Work programme topics:</b> HEALTH Innovative and personalized medicine</p><p _ngcontent-bbw-c15=""><b _ngcontent-bbw-c15="">EU FP7 Call:</b> H2020-SCI1-2016-RTD</p><p _ngcontent-bbw-c15="" class="m-y-s"><b _ngcontent-bbw-c15="">Proposal number:</b> 733100</p><p _ngcontent-bbw-c15=""><b _ngcontent-bbw-c15="">Duration:</b> 60 months (1st January 2017 – 31st March 2022)</p><p _ngcontent-bbw-c15="" class="m-y-s"><b _ngcontent-bbw-c15="">Host institution:</b> Genos (third party Faculty of Science University of Zagreb)</p><p _ngcontent-bbw-c15=""><b _ngcontent-bbw-c15="">Coordinating person:</b> Professor Philip Rosenstiel, PhD, Christian-Albrechts-University Kiel with University Hospital Schleswig Holstein, Campus Kiel</p><p _ngcontent-bbw-c15="" class="m-y-s"><b _ngcontent-bbw-c15="">EU Funding to Genos and Faculty of Science:</b> 880,000.00 Eur</p><p _ngcontent-bbw-c15=""><b _ngcontent-bbw-c15="">Detailed information:</b> http://syscid.eu/home/</p></div></section></zg-test-block></zg-page><footer _ngcontent-bbw-c9=""></footer></zg-layout></zg-root><noscript>Please enable JavaScript to continue using this application.</noscript><script src="runtime-es2015.1eba213af0b233498d9d.js" type="module"></script><script src="runtime-es5.1eba213af0b233498d9d.js" nomodule="" defer></script><script src="polyfills-es5.ef2b553afea95784ae26.js" nomodule="" defer></script><script src="polyfills-es2015.6f102767e288ad0fd189.js" type="module"></script><script src="main-es2015.b7d34fc3addb5a3af02b.js" type="module"></script><script src="main-es5.b7d34fc3addb5a3af02b.js" nomodule="" defer></script></body></html>